You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 13, 2024

BUTALBITAL AND ACETAMINOPHEN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Butalbital And Acetaminophen, and what generic alternatives are available?

Butalbital And Acetaminophen is a drug marketed by Dr Reddys Labs Sa, Granules, Alvogen, Halsey, Larken Labs Inc, Lgm Pharma, Mikart, Ne Rx Pharma, Quagen, Senores Pharms, and Watson Labs. and is included in thirteen NDAs.

The generic ingredient in BUTALBITAL AND ACETAMINOPHEN is acetaminophen; butalbital. There are sixty-six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital profile page.

Drug patent expirations by year for BUTALBITAL AND ACETAMINOPHEN
Recent Clinical Trials for BUTALBITAL AND ACETAMINOPHEN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Federal University of São PauloPhase 4
Fundação de Amparo à Pesquisa do Estado de São PauloPhase 4
GlaxoSmithKlinePhase 3

See all BUTALBITAL AND ACETAMINOPHEN clinical trials

Pharmacology for BUTALBITAL AND ACETAMINOPHEN
Drug ClassBarbiturate

US Patents and Regulatory Information for BUTALBITAL AND ACETAMINOPHEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Sa BUTALBITAL AND ACETAMINOPHEN acetaminophen; butalbital CAPSULE;ORAL 207313-001 Dec 27, 2017 AA RX No Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Lgm Pharma BUTALBITAL AND ACETAMINOPHEN acetaminophen; butalbital TABLET;ORAL 090956-001 Aug 23, 2011 AA RX No Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Alvogen BUTALBITAL AND ACETAMINOPHEN acetaminophen; butalbital TABLET;ORAL 205120-001 Oct 30, 2015 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.